| 1 |
35074014 | Blood bacterial resistant investigation collaborative system (BRICS) report: a national surveillance in China from 2014 to 2019. | 2022 Jan 24 |
1 |
| 2 |
35091052 | Prevalence of ESBL non-CRE Escherichia coli and Klebsiella pneumoniae among clinical isolates collected by the SMART global surveillance programme from 2015 to 2019. | 2022 Mar |
1 |
| 3 |
35335681 | Antimicrobial Resistance in Enterobacterales Recovered from Urinary Tract Infections in France. | 2022 Mar 15 |
1 |
| 4 |
35418762 | Community Fecal Carriage and Molecular Epidemiology of Extended-Spectrum β-Lactamase- and Carbapenemase-Producing Escherichia coli from Healthy Children in the Central South China. | 2022 |
1 |
| 5 |
35482377 | Antibiotic resistance pattern and molecular detection of ESBL-associated genes in E. coli from surface and wastewater of Islamabad capital territory, Pakistan. | 2022 Apr |
1 |
| 6 |
35517902 | Antimicrobial Susceptibility Trends Among Gram-Negative Bacilli Causing Bloodstream Infections: Results from the China Antimicrobial Resistance Surveillance Trial (CARST) Program, 2011-2020. | 2022 |
1 |
| 7 |
33164081 | IS26-mediated amplification of blaOXA-1 and blaCTX-M-15 with concurrent outer membrane porin disruption associated with de novo carbapenem resistance in a recurrent bacteraemia cohort. | 2021 Jan 19 |
3 |
| 8 |
33437247 | High frequency of simultaneous presence of ESBL and carbapenemase producers among nosocomial coliform isolates in Faisalabad, Pakistan. | 2021 Jan-Feb |
2 |
| 9 |
33683048 | Antibiogram and Molecular Characterization of AmpC and ESBL-Producing Gram-Negative Bacteria from Poultry and Abattoir Samples. | 2021 Jan |
1 |
| 10 |
33691795 | Prevalence of multidrug-resistant and extended-spectrum beta-lactamase producing Gram-negative isolates from clinical samples in a tertiary care hospital of Nepal. | 2021 Mar 11 |
1 |
| 11 |
34223107 | Risk factors and outcome associated with infection or colonization due to carbapenem-heteroresistant Escherichia coli. | 2021 Mar |
1 |
| 12 |
34490146 | Antibiotic Resistance Pattern of Extended Spectrum Beta Lactamase Producing Escherichia coli Isolated From Patients With Urinary Tract Infection in Morocco. | 2021 |
1 |
| 13 |
34540152 | Antimicrobial resistance pattern in healthcare-associated infections: investigation of in-hospital risk factors. | 2021 Apr |
2 |
| 14 |
34566340 | Antibacterial activity of clove (Syzygium aromaticum) and cinnamon (Cinnamomum burmannii) essential oil against extended-spectrum β-lactamase-producing bacteria. | 2021 Aug |
1 |
| 15 |
34853981 | Cefmetazole as an Alternative to Carbapenems Against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Infections Based on In Vitro and In Vivo Pharmacokinetics/Pharmacodynamics Experiments. | 2021 Nov |
1 |
| 16 |
31954833 | Faropenem resistance causes in vitro cross-resistance to carbapenems in ESBL-producing Escherichia coli. | 2020 Mar |
3 |
| 17 |
32274352 | Community Acquired Urosepsis: A surgical intensive care Experience. | 2020 |
1 |
| 18 |
32602298 | Phenotypic and genotypic detection of ESBL-producing E. coli isolates from chicken skin in Bosnia and Herzegovina. | 2020 Aug 1 |
1 |
| 19 |
32840305 | Impact of reflex fosfomycin susceptibility testing on the utilization of carbapenems for definitive extended-spectrum β-lactamase Escherichia coli urinary tract infection treatment. | 2020 Nov 16 |
1 |
| 20 |
30509935 | Carbapenem versus Cefepime or Piperacillin-Tazobactam for Empiric Treatment of Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli in Patients with Hematologic Malignancy. | 2019 Feb |
1 |
| 21 |
30942772 | Survey of US wastewater for carbapenem-resistant Enterobacteriaceae. | 2019 Apr |
1 |
| 22 |
31408445 | Spreading of extended-spectrum β-lactamase-producing Escherichia coli ST131 and Klebsiella pneumoniae ST11 in patients with pneumonia: a molecular epidemiological study. | 2019 Aug 20 |
1 |
| 23 |
31558390 | Adverse clinical outcomes associated with multidrug-resistant organisms in patients with infected pancreatic necrosis. | 2019 Oct |
1 |
| 24 |
31821338 | The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017. | 2019 |
2 |
| 25 |
32120467 | Prevalence, antibiotic sensitivity pattern and genetic analysis of extended spectrum beta lactamase producing Escherichia coli and Klebsiella spp among patients with community acquired urinary tract infection in Galle district, Sri Lanka | 2019 Dec 31 |
2 |
| 26 |
33536830 | Trend in Antibiotic Resistance of Extended-Spectrum Beta-Lactamase-Producing Escherichia Coli and Klebsiella Pneumoniae Bloodstream Infections. | 2019 |
1 |
| 27 |
30146823 | Molecular and Phenotypic Study of Carbapenem Resistant E. coli. | 2018 Jul 1 |
1 |
| 28 |
30237728 | Appropriate composites of cefoperazone-sulbactam against multidrug-resistant organisms. | 2018 |
1 |
| 29 |
30377552 | Early-Onset Neonatal Sepsis with Extended Spectrum Beta-Lactamase Producing Escherichia Coli in Infants Born to South and South East Asian Immigrants: A Case Series. | 2018 Oct |
1 |
| 30 |
30534919 | [Evaluation of susceptibility and response to therapy with piperacillin-tazobactam in patients with infections caused by Escherichia coli with extended-spectrum β-lactamase (ESBL) CTX-M]. | 2018 Aug |
2 |
| 31 |
30581868 | Infections Caused by Extended-Spectrum β-Lactamase Producing Escherichia Coli in Systemic Lupus Erythematosus Patients: Prevalence, Risk Factors, and Predictive Model. | 2018 |
1 |
| 32 |
30613678 | Post-appendectomy pelvic abscess with extended-spectrum beta-lactamase producing Escherichia coli: A case report and review of literature. | 2018 Dec 26 |
1 |
| 33 |
26423244 | Fluoroquinolone therapy for bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. | 2017 Jun |
3 |
| 34 |
28420242 | High prevalence of NDM metallo-β-lactamase among ESBL-producing Escherichia coli İsolates. | 2017 Jun 1 |
1 |
| 35 |
28458485 | Phenotypic Detection of Extended Spectrum Beta lactamase and Carbapenemase Co-producing Clinical Isolates from Two Tertiary Hospitals in Kano, North West Nigeria. | 2017 Jan |
1 |
| 36 |
28643188 | Impact of appropriateness of empiric therapy on outcomes in community-onset bacteremia by extended-spectrum-β-lactamase producing Escherichia coli and Klebisella pneumoniae definitively treated with carbapenems. | 2017 Nov |
1 |
| 37 |
29262709 | Chemical composition and antimicrobial activity of the commercial Origanum onites L. oil against nosocomial carbapenem resistant extended spectrum beta lactamase producer Escherichia coli isolates. | 2017 Dec |
1 |
| 38 |
26194952 | Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. isolates in Mongolia. | 2016 Oct |
1 |
| 39 |
26511749 | Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years. | 2016 Jul |
1 |
| 40 |
26513341 | Pediatric extended spectrum β-lactamase infection: Community-acquired infection and treatment options. | 2016 May |
1 |
| 41 |
27104951 | Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae. | 2016 |
1 |
| 42 |
27574974 | High Gastrointestinal Colonization Rate with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Hospitalized Patients: Emergence of Carbapenemase-Producing K. pneumoniae in Ethiopia. | 2016 |
1 |
| 43 |
25649300 | Impact of carbapenem heteroresistance among clinical isolates of invasive Escherichia coli in Chongqing, southwestern China. | 2015 May |
1 |
| 44 |
25716293 | β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options? | 2015 Apr |
1 |
| 45 |
26028418 | [Evaluation of Antibiotics for the Treatment of Bacteremia Due to Extended-spectrum β-Lactamase-producing Escherichia coli]. | 2015 |
2 |
| 46 |
26464143 | Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae. | 2015 Oct 13 |
4 |
| 47 |
26675893 | Risk Factor Analysis in Clinical Isolates of ESBL and MBL (Including NDM-1) Producing Escherichia coli and Klebsiella Species in a Tertiary Care Hospital. | 2015 Nov |
1 |
| 48 |
24478449 | Evaluation of the Clinical and Laboratory Standards Institute phenotypic confirmatory test to detect the presence of extended-spectrum β-lactamases from 4005 Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae and Proteus mirabilis isolates. | 2014 Apr |
1 |
| 49 |
24676243 | [In vitro emergence of ertapenem resistance in Escherichia coli producing extended-spectrum β-lactamase]. | 2014 Mar |
1 |
| 50 |
24928854 | The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli. | 2014 Oct |
3 |